Kaur, S., Michael, H., Arora, S., Harkonen, P. L., and Kumar, S. The in vitro cytotoxic and apoptotic activity of Triphala--an Indian herbal drug. J Ethnopharmacol. 2-10-2005;97(1):15-20. View abstract.
Manjunatha, S., Jaryal, A. K., Bijlani, R. L., Sachdeva, U., and Gupta, S. K. Effect of Chyawanprash and vitamin C on glucose tolerance and lipoprotein profile. Indian J Physiol Pharmacol 2001;45(1):71-79. View abstract.
Rege, N. N., Thatte, U. M., and Dahanukar, S. A. Adaptogenic properties of six rasayana herbs used in Ayurvedic medicine. Phytother.Res 1999;13(4):275-291. View abstract.
Sabu, M. C. and Kuttan, R. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol. 2002;81(2):155-160. View abstract.
Scartezzini, P. and Speroni, E. Review on some plants of Indian traditional medicine with antioxidant activity. J Ethnopharmacol. 2000;71(1-2):23-43. View abstract.
Shanmugasundaram, K. R., Seethapathy, P. G., and Shanmugasundaram, E. R. Anna Pavala Sindhooram--an antiatherosclerotic Indian drug. J.Ethnopharmacol. 1983;7(3):247-265. View abstract.
Sharma, N., Trikha, P., Athar, M., and Raisuddin, S. In vitro inhibition of carcinogen-induced mutagenicity by Cassia occidentalis and Emblica officinalis. Drug Chem.Toxicol. 2000;23(3):477-484. View abstract.
Srikumar, R., Parthasarathy, N. J., Shankar, E. M., Manikandan, S., Vijayakumar, R., Thangaraj, R., Vijayananth, K., Sheeladevi, R., and Rao, U. A. Evaluation of the growth inhibitory activities of Triphala against common bacterial isolates from HIV infected patients. Phytother.Res. 2007;21(5):476-480. View abstract.
Yokozawa, T., Kim, H. Y., Kim, H. J., Okubo, T., Chu, D. C., and Juneja, L. R. Amla (Emblica officinalis Gaertn.) prevents dyslipidaemia and oxidative stress in the ageing process. Br.J Nutr. 2007;97(6):1187-1195. View abstract.
Anila L, Vijayalakshmi NR. Beneficial effects of flavonoids from Sesamum indicum, Emblica officinalis and Momordica charantia. Phytother Res 2000;14:592-5. View abstract.
Antony B, Benny M, Kaimal TN. A pilot clinical study to evaluate the effect of Emblica officinalis extract (Amlamax) on markers of systemic inflammation and dyslipidemia. Indian J Clin Biochem. 2008;23(4):378-81. View abstract.
Asmawi MZ, Kankaanranta H, Moilanen E, Vapaatalo H. Anti-inflammatory activities of Emblica officinalis Gaertn leaf extracts. J Pharm Pharmacol 1993;45:581-4. View abstract.
Bhattacharya A, Chatterjee A, Ghosal S, Bhattacharya SK. Antioxidant activity of active tannoid principles of Emblica officinalis (amla). Indian J Exp Biol 1999;37:676-80. View abstract.
Chaudhuri, R. K. Emblica cascading antioxidant: a novel natural skin care ingredient. Skin Pharmacol Appl Skin Physiol 2002;15(5):374-380. View abstract.
Chevallier A. Encyclopedia of Medicinal Plants. New York, NY: DK Publishing 1996;202.
Chopra A, Saluja M, Tillu G, Sarmukkaddam S, Venugopalan A, Narsimulu G, Handa R, Sumantran V, Raut A, Bichile L, Joshi K, Patwardhan B. Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial. Rheumatology (Oxford) 2013;52(8):1408-17. View abstract.
Colucci R, Dragoni F, Conti R, Pisaneschi L, Lazzeri L, Moretti S. Evaluation of an oral supplement containing Phyllanthus emblica fruit extracts, vitamin E, and carotenoids in vitiligo treatment. Dermatol Ther. 2015;28(1):17-21. View abstract.
Al Rehaily, A. J., Al Howiriny, T. A., Al Sohaibani, M. O., and Rafatullah, S. Gastroprotective effects of 'Amla' Emblica officinalis on in vivo test models in rats. Phytomedicine. 2002;9(6):515-522. View abstract.
Bafna, P. A. and Balaraman, R. Anti-ulcer and anti-oxidant activity of pepticare, a herbomineral formulation. Phytomedicine. 2005;12(4):264-270. View abstract.
Jose, J. K., Kuttan, G., and Kuttan, R. Antitumour activity of Emblica officinalis. J Ethnopharmacol. 2001;75(2-3):65-69. View abstract.
Dev S. Ancient-modern concordance in Ayurvedic plants: some examples. Environ Health Perspect 1999;107:783-9. View abstract.
Fatima N, Pingali U, Muralidhar N. Study of pharmacodynamic interaction of Phyllanthus emblica extract with clopidogrel and ecosprin in patients with type II diabetes mellitus. Phytomedicine. 2014;21(5):579-85. View abstract.
Gao Q, Li X, Huang H, Guan Y, Mi Q, Yao J. The efficacy of a chewing gum containing Phyllanthus emblica fruit extract in improving oral health. Curr Microbiol. 2018;75(5):604-610. View abstract.
Gopa B, Bhatt J, Hemavathi KG. A comparative clinical study of hypolipidemic efficacy of Amla (Emblica officinalis) with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitor simvastatin. Indian J Pharmacol. 2012;44(2):238-42. View abstract.
GRIN Taxonomy. Available at: https://www.ars-grin.gov/cgi-bin/npgs/html/tax_search.pl? (Accessed 27 February 2000).
Hu JF. [Inhibitory effects of Phyllanthus emblica juice on formation of N-nitrosomorpholine in vitro and N-nitrosoproline in rat and human]. Chung Hua Yu Fang I Hsueh Tsa Chih 1990;24:132-5. View abstract.
Ihantola-Vormisto A, Summanen J, Kankaanranta H, et al. Anti-inflammatory activity of extracts from leaves of Phyllanthus emblica. Planta Med 1997;63:518-24. View abstract.
Jacob A, Pandey M, Kapoor S, Saroja R. Effect of the Indian gooseberry (amla) on serum cholesterol levels in men aged 35-55 years. Eur J Clin Nutr 1988;42:939-44. View abstract.
Kapoor MP, Suzuki K, Derek T, Ozeki M, Okubo T. Clinical evaluation of Emblica Officinalis Gatertn (Amla) in healthy human subjects: health benefits and safety results from a randomized, double-blind, crossover placebo-controlled study. Contemp Clin Trials Commun 2019;17:100499. View abstract.
Karkon Varnosfaderani S, Hashem-Dabaghian F, Amin G, et al. Efficacy and safety of Amla (Phyllanthus emblica L.) in non-erosive reflux disease: a double-blind, randomized, placebo-controlled clinical trial. J Integr Med. 2018;16(2):126-131. View abstract.
Khanna S, Das A, Spieldenner J, Rink C, Roy S. Supplementation of a standardized extract from Phyllanthus emblica improves cardiovascular risk factors and platelet aggregation in overweight/class-1 obese adults. J Med Food. 2015;18(4):415-20. View abstract.
Uchiyama T, Tsunenaga M, Miyanaga M, Ueda O, Ogo M. Oral intake of lingonberry and amla fruit extract improves skin conditions in healthy female subjects: a randomized, double-blind, placebo-controlled clinical trial. Biotechnol Appl Biochem 2019;66(5):870-9. View abstract.
Upadya H, Prabhu S, Prasad A, Subramanian D, Gupta S, Goel A. A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia. BMC Complement Altern Med. 2019;19(1):27. View abstract.
Usharani P, Merugu PL, Nutalapati C. Evaluation of the effects of a standardized aqueous extract of Phyllanthus emblica fruits on endothelial dysfunction, oxidative stress, systemic inflammation and lipid profile in subjects with metabolic syndrome: a randomised, double blind, placebo controlled clinical study. BMC Complement Altern Med 2019;19(1):97. View abstract.